RLYB - Rallybio prices $50M securities offering

• Rallybio Corporation ( NASDAQ: RLYB ) has priced an underwritten public offering of 5M shares of its common stock at a price to the public of $6.00/share and, in lieu of common stock to certain investors, pre-funded warrants to purchase up to an aggregate of 3,333,388 shares of its common stock at a price of $5.9999 per pre-funded warrant.
• All of the shares and pre-funded warrants are being offered by Rallybio.
• The gross proceeds from the offering are expected to be approximately $50M.
• The offering is expected to close on November 15, 2022.
• Underwriters are granted a 30-day option to purchase up to an additional 1.25M shares of its common stock at the public offering price.

For further details see: